Lockerman Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Sell |
1,480
-64
| -4% | -$11.9K | 0.37% | 96 |
|
|
2025
Q1 | $324K | Buy |
1,544
+137
| +10% | +$28.7K | 0.49% | 69 |
|
|
2024
Q4 | $250K | Buy |
1,407
+117
| +9% | +$20.8K | 0.43% | 82 |
|
|
2024
Q3 | $255K | Sell |
1,290
-173
| -12% | -$34.2K | 0.43% | 89 |
|
|
2024
Q2 | $251K | Buy |
1,463
+299
| +26% | +$51.3K | 0.46% | 84 |
|
|
2024
Q1 | $212K | Buy |
+1,164
| New | +$212K | 0.41% | 102 |
|
|
2023
Q1 | – | Sell |
-1,357
| Closed | -$219K | – | 74 |
|
|
2022
Q4 | $219K | Buy |
+1,357
| New | +$219K | 0.64% | 64 |
|